Colony Bankcorp (CBAN) AI Stock Analysis

• Market Cap: $444.85M
• Dividend Yield: 2.55%
• Average Volume (3M): 75.55K
• Price to Earnings (P/E): 12.9
• Beta (1Y): 0.89
• Revenue Growth: 6.92%
• EPS Growth: 26.93%
• Country: US
• Employees: 443
• Sector: Financial
• Sector Strength: 70
• Industry: Banks - Regional
• EPS (TTM): 0.48
• Shares Outstanding: 21,274,380
• 10 Day Avg. Volume: 112,396
• 30 Day Avg. Volume: 75,549
• PEG Ratio: 1.23
• Price to Book (P/B): 1.02
• Price to Sales (P/S): 1.60
• P/FCF Ratio: 12.70
• Enterprise Value/Market Cap: 0.77
• Enterprise Value/Revenue: 1.86
• Enterprise Value/Gross Profit: 2.81
• Enterprise Value/Ebitda: 8.23
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 74 Outperform
• Price Target: $20.50 ▲(20.59% Upside)

The score is driven primarily by solid financial performance (growth and generally good cash conversion), supported by an improving technical trend and reasonable valuation with a dividend. Earnings-call and recent corporate actions add a modest positive tilt, while cash-flow volatility, leverage/reporting comparability, and some credit/expense pressures temper the upside.

Positive Factors

Merger with TC Bancshares

The merger with TC Bancshares significantly enhances Colony Bankcorp's market position and service capabilities in key Southeast markets, potentially driving long-term growth and competitive advantage.

Net Interest Margin Expansion

The expansion in net interest margin reflects effective pricing strategies and loan growth, contributing to improved profitability and financial stability over the long term.

Strong Free Cash Flow Growth

Robust free cash flow growth indicates strong cash generation capabilities, enhancing financial flexibility and supporting future investments and debt management.

Negative Factors

Rising Operating Expenses

Increased operating expenses due to investments in talent and growth initiatives could pressure margins and reduce profitability if not offset by revenue growth.

Higher Charge-offs in SBA Division

Higher charge-offs in the SBA division may indicate credit quality issues, potentially impacting future earnings and necessitating more conservative lending practices.

Slowdown in Mortgage and SBSL Divisions

A slowdown in mortgage and SBSL divisions due to changes in SBA lending guidelines and a slower housing market could limit revenue growth in these segments.

Colony Bankcorp Business Overview & Revenue Model

Company Description

Colony Bankcorp (CBAN) is a publicly traded bank holding company based in Georgia, primarily engaged in providing a range of banking and financial services through its subsidiary, Colony Bank. The company operates in the financial services sector and offers products such as personal and commercial banking, mortgage loans, and treasury management services. Colony Bank caters to individuals, small to medium-sized businesses, and various organizations, focusing on community-oriented banking solutions.

How the Company Makes Money

Colony Bankcorp generates revenue primarily through interest income from loans and investments, which constitutes a significant portion of its earnings. The company offers various types of loans, including commercial loans, consumer loans, and real estate mortgages, earning interest on these financial products. Additionally, Colony Bankcorp earns non-interest income through service fees, transaction fees, and other banking services, including wealth management and treasury services. The bank also benefits from strategic partnerships that may enhance its service offerings and customer base, contributing positively to its overall financial performance.

Colony Bankcorp Financial Statement Overview

Summary

Solid fundamentals with sustained revenue and net income growth and generally good cash conversion of earnings. The main offsets are volatility in cash flows (including historical negative operating/free cash flow) and inconsistencies in leverage presentation (TTM reported zero debt vs. prior years), which reduce confidence in trend stability.

Income Statement

Revenue has grown consistently from 2020 through 2024, and TTM (Trailing-Twelve-Months) revenue is up strongly versus the prior period (revenue growth rate ~1.26). Profitability is solid and improving in absolute dollars (net income rising from ~$11.8M in 2020 to ~$23.9M in 2024 and ~$27.8M TTM). Margins appear healthy in TTM, but reported gross margin is volatile across years (including several 100% readings), which limits confidence in margin comparability year-to-year.

Balance Sheet

The company shows steady equity growth (from ~$144.5M in 2020 to ~$278.7M in 2024 and ~$302.3M TTM) alongside a larger asset base, supporting balance-sheet expansion. Returns on equity are consistent in the high-single-digits (~8%–10% range), indicating stable profitability relative to capital. Leverage looks moderate-to-elevated in recent annual periods (debt-to-equity ~0.88–0.94 in 2022–2024), though TTM reports zero debt and a 0.0 debt-to-equity ratio, which is a sharp shift versus history and may reflect reporting classification differences—so leverage risk should be monitored.

Cash Flow

Cash generation is generally supportive of earnings, with free cash flow tracking net income closely (free cash flow to net income ~0.83–0.97 from 2021 to TTM). However, cash flow has been volatile: 2020 had negative operating and free cash flow, and free cash flow growth swings meaningfully (down in 2023, modestly up in 2024, and down again in TTM). TTM operating and free cash flow are strong in absolute terms (~$45.0M and ~$44.4M), but the uneven trajectory reduces quality/stability versus a higher-scoring peer.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	184.78M	176.62M	160.55M	126.56M	106.88M	87.37M
Gross Profit	122.55M	112.40M	110.28M	112.33M	101.78M	72.93M
EBITDA	41.87M	37.70M	35.91M	34.48M	31.78M	20.49M
Net Income	27.84M	23.87M	21.75M	19.54M	18.66M	11.81M
Balance Sheet
Total Assets	3.15B	3.11B	3.05B	2.94B	2.69B	1.76B
Cash, Cash Equivalents and Short-Term Investments	364.55M	64.84M	432.72M	453.14M	957.14M	398.03M
Total Debt	185.00M	248.04M	238.44M	203.35M	88.45M	60.29M
Total Liabilities	2.85B	2.83B	2.80B	2.71B	2.47B	1.62B
Stockholders Equity	302.33M	278.68M	254.94M	230.27M	217.71M	144.49M
Cash Flow
Free Cash Flow	44.39M	22.32M	17.36M	46.85M	30.27M	-23.34M
Operating Cash Flow	44.96M	23.40M	20.98M	49.74M	36.10M	-19.09M
Investing Cash Flow	-38.77M	101.16M	-98.75M	-448.23M	-208.33M	-130.27M
Financing Cash Flow	48.92M	23.15M	80.41M	281.93M	185.95M	228.77M

Colony Bankcorp Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 17.00
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Negative
• STOCH: Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For CBAN, the sentiment is Positive. The current price of 17 is below the 20-day moving average (MA) of 18.91, below the 50-day MA of 18.21, and above the 200-day MA of 16.74, indicating a bullish trend. The MACD of 0.60 indicates Negative momentum. The RSI at 76.81 is Negative, neither overbought nor oversold. The STOCH value of 90.06 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for CBAN.

Colony Bankcorp Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
FNLC	77 Outperform	$326.71M	9.24	11.86%	5.24%	10.46%	18.70%
FSBW	75 Outperform	$319.31M	9.92	10.77%	3.17%	4.43%	-12.94%
CBAN	74 Outperform	$444.85M	12.91	9.63%	2.55%	6.92%	26.93%
CZNC	74 Outperform	$420.48M	16.04	9.42%	5.43%	5.76%	21.85%
PLBC	73 Outperform	$365.93M	11.52	12.34%	2.63%	11.98%	-10.12%
PCB	72 Outperform	$336.27M	9.01	9.38%	3.57%	10.93%	42.68%
Sector *	68 Neutral	$18.00B	11.42	9.92%	3.81%	9.73%	1.22%

Colony Bankcorp Corporate Events

Colony Bankcorp Posts Strong Q4 Results, Raises Dividend

On January 24, 2026, Colony Bank renewed Chief Financial Officer Derek Shelnutt’s employment with a new two-year agreement that maintains him as CFO of both the holding company and the bank, sets a $300,000 annual base salary with performance-based bonus eligibility, and outlines severance protections of up to 1.5 times salary and prior-year bonus in certain termination and change-in-control scenarios, alongside non-compete and non-solicitation covenants. On January 28, 2026, the company reported stronger fourth-quarter 2025 results, with net income rising to $7.8 million and operating net income to $8.9 million, driven by higher net interest income, an expanded net interest margin, loan and deposit growth largely tied to the December 1, 2025 acquisition of TC Bancshares’ TC Federal, and higher noninterest income, while also noting increased credit loss provisions, higher noninterest expenses from integration costs and a wire-fraud loss, a larger credit loss reserve, and a solid capital position; the board raised the quarterly dividend to $0.12 per share, underscoring confidence in the bank’s capital strength and earnings trajectory for shareholders.

The most recent analyst rating on (CBAN) stock is a Buy with a $21.50 price target. To see the full list of analyst forecasts on Colony Bankcorp stock, see the CBAN Stock Forecast page.

Colony Bankcorp Extends Common Stock Repurchase Program

On December 18, 2025, Colony Bankcorp’s board of directors extended the company’s existing stock repurchase program, originally approved in October 2022 and previously extended in December 2024, allowing the company to continue buying back up to $12 million of its common stock through the end of 2026. The company has repurchased 318,778 shares totaling $4.613 million since the program began, leaving $7.387 million available; the revised authorization preserves flexibility on timing, volume, and methods of repurchase, reflecting ongoing capital management priorities while allowing the company to adjust or terminate the program based on market conditions, regulatory requirements, and liquidity needs.

The most recent analyst rating on (CBAN) stock is a Buy with a $20.00 price target. To see the full list of analyst forecasts on Colony Bankcorp stock, see the CBAN Stock Forecast page.

Colony Bankcorp Completes Merger with TC Bancshares

On December 1, 2025, Colony Bankcorp, Inc. completed its merger with TC Bancshares, Inc., resulting in Colony Bankcorp becoming one of the leading community banks in the Southeast with approximately $3.7 billion in total assets. TC Bancshares shareholders received either cash or Colony common stock as part of the merger agreement. The merger is expected to expand Colony’s presence and deepen its service across key Georgia and Florida markets, with full integration anticipated in early 2026.

The most recent analyst rating on (CBAN) stock is a Buy with a $18.50 price target. To see the full list of analyst forecasts on Colony Bankcorp stock, see the CBAN Stock Forecast page.

Colony Bankcorp Receives Approval for TC Bancshares Merger

On November 13, 2025, Colony Bankcorp, Inc. held a special meeting where shareholders approved the issuance of common stock for a merger with TC Bancshares, Inc., and the adjournment proposal to solicit additional proxies if needed. By November 17, 2025, the company announced it had received all necessary regulatory approvals for the merger, which is expected to close on December 1, 2025. This merger positions Colony as a leading community bank in the Southeast with approximately $3.8 billion in total assets, enhancing its market presence and service capabilities.

The most recent analyst rating on (CBAN) stock is a Buy with a $18.50 price target. To see the full list of analyst forecasts on Colony Bankcorp stock, see the CBAN Stock Forecast page.

Colony Bankcorp Enters Equity Distribution Agreement

On November 3, 2025, Colony Bankcorp, Inc. and its subsidiary, Colony Bank, entered into an Equity Distribution Agreement with Piper Sandler & Co. to issue and sell up to $40 million of the company’s common stock. The proceeds from this offering are intended for general corporate purposes, including supporting the bank’s lending and investing activities, repaying debt, and funding strategic initiatives. The agreement allows for flexible sales methods and includes customary terms and conditions, with no obligation for the company to sell any stock.

The most recent analyst rating on (CBAN) stock is a Buy with a $18.50 price target. To see the full list of analyst forecasts on Colony Bankcorp stock, see the CBAN Stock Forecast page.